BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38065948)

  • 1. m6A and m5C modification of GPX4 facilitates anticancer immunity via STING activation.
    Chen B; Hong Y; Zhai X; Deng Y; Hu H; Tian S; Zhang Y; Ren X; Zhao J; Jiang C
    Cell Death Dis; 2023 Dec; 14(12):809. PubMed ID: 38065948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox homeostasis maintained by GPX4 facilitates STING activation.
    Jia M; Qin D; Zhao C; Chai L; Yu Z; Wang W; Tong L; Lv L; Wang Y; Rehwinkel J; Yu J; Zhao W
    Nat Immunol; 2020 Jul; 21(7):727-735. PubMed ID: 32541831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NSUN6 mediates 5-methylcytosine modification of METTL3 and promotes colon adenocarcinoma progression.
    Cui Y; Lv P; Zhang C
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23749. PubMed ID: 38800929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the m6A-related lncRNA signature in predicting prognosis and immune response in patients with colon cancer.
    Chen S; Li X; Guo L; Zhang J; Li L; Wang X; Zhu Y; Wang J
    J BUON; 2021; 26(5):1931-1941. PubMed ID: 34761602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of m6A regulators and relationship with tumor microenvironment, immunotherapy strategies in colorectal adenocarcinoma.
    Ji J; Liu S; Liang Y; Zheng G
    BMC Genom Data; 2023 Aug; 24(1):44. PubMed ID: 37568073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteolin exhibits synergistic therapeutic efficacy with erastin to induce ferroptosis in colon cancer cells through the HIC1-mediated inhibition of GPX4 expression.
    Zheng Y; Li L; Chen H; Zheng Y; Tan X; Zhang G; Jiang R; Yu H; Lin S; Wei Y; Wang Y; Zhang R; Liu Z; Wu J
    Free Radic Biol Med; 2023 Nov; 208():530-544. PubMed ID: 37717793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer.
    Storozynsky Q; Hitt MM
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cGAS/STING cross-talks with cell cycle and potentiates cancer immunotherapy.
    Long ZJ; Wang JD; Xu JQ; Lei XX; Liu Q
    Mol Ther; 2022 Mar; 30(3):1006-1017. PubMed ID: 35121107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
    Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
    Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
    He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
    Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA methylation-related genes of m6A, m5C, and m1A predict prognosis and immunotherapy response in cervical cancer.
    Wang Y; Mao Y; Wang C; Jiang X; Tang Q; Wang L; Zhu J; Zhao M
    Ann Med; 2023 Dec; 55(1):2190618. PubMed ID: 37042849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A General Biomineralization Strategy to Synthesize Autologous Cancer Vaccines with cGAS-STING Activating Capacity for Postsurgical Immunotherapy.
    Li Q; Dong Z; Cao Z; Lei H; Wang C; Hao Y; Feng L; Liu Z
    ACS Nano; 2023 Jun; 17(11):10496-10510. PubMed ID: 37184402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cGAS/STING Pathway: A Novel Target for Cancer Therapy.
    Gan Y; Li X; Han S; Liang Q; Ma X; Rong P; Wang W; Li W
    Front Immunol; 2021; 12():795401. PubMed ID: 35046953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel m6A/m5C/m1A score signature to evaluate prognosis and its immunotherapy value in colon cancer patients.
    Liu J; Dou M; Liu X; Lu Y; Lu W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11995-12012. PubMed ID: 37421455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cyclic guanosine monophosphate synthase-stimulator of interferon genes pathway as a potential target for tumor immunotherapy.
    Chen R; Liu M; Jiang Q; Meng X; Wei J
    Front Immunol; 2023; 14():1121603. PubMed ID: 37153627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Analysis of the Expression and Association with Immune Cell Infiltration of the cGAS/STING Pathway in Pan-Cancer.
    An X; Zhu Y; Zheng T; Wang G; Zhang M; Li J; Ji H; Li S; Yang S; Xu D; Li Z; Wang T; He Y; Zhang L; Yang W; Zhao R; Hao D; Li X
    Mol Ther Nucleic Acids; 2019 Mar; 14():80-89. PubMed ID: 30583098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cGAS-STING pathway-related gene signature can predict patient prognosis and immunotherapy responses in prostate adenocarcinoma.
    Zhuo X; Dai H; Yu S
    Medicine (Baltimore); 2022 Dec; 101(50):e31290. PubMed ID: 36550819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Cytosolic DNA Sensor cGAS-STING as Immune-Related Risk Factor in Renal Carcinoma following Pan-Cancer Analysis.
    Wu Z; Lin Y; Liu LM; Hou YL; Qin WT; Zhang L; Jiang SH; Yang Q; Bai YR
    J Immunol Res; 2022; 2022():7978042. PubMed ID: 35983076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin.
    Zhang X; Sui S; Wang L; Li H; Zhang L; Xu S; Zheng X
    J Cell Physiol; 2020 Apr; 235(4):3425-3437. PubMed ID: 31556117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.